News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,379 Results
Type
Article (226)
Company Profile (3)
Press Release (7150)
Section
Business (1926)
Career Advice (50)
Deals (389)
Drug Development (1495)
FDA (245)
Job Trends (208)
News (3907)
Policy (259)
Tag
Academia (28)
Allergies (2)
Alliances (322)
ALS (1)
Alzheimer's disease (32)
Antibody-drug conjugate (ADC) (17)
Approvals (260)
Artificial intelligence (7)
Autoimmune disease (5)
Bankruptcy (2)
Best Places to Work (213)
Biosimilars (3)
Biotechnology (1)
Bladder cancer (6)
Breast cancer (46)
Cancer (143)
Cardiovascular disease (13)
Career advice (34)
CAR-T (3)
Cell therapy (14)
Clinical research (1422)
Collaboration (15)
Compensation (7)
COVID-19 (42)
C-suite (12)
Data (197)
Depression (7)
Diabetes (4)
Diagnostics (69)
Drug discovery (2)
Duchenne muscular dystrophy (2)
Earnings (1027)
Events (1092)
Executive appointments (14)
FDA (304)
Funding (15)
Gene editing (2)
Gene therapy (7)
GLP-1 (15)
Government (33)
Guidances (9)
Healthcare (253)
HIV (1)
Huntington's disease (1)
Immunology and inflammation (2)
Immuno-oncology (3)
Indications (2)
Infectious disease (49)
Inflammatory bowel disease (3)
Influenza (2)
Intellectual property (5)
Interviews (9)
IPO (245)
Job creations (17)
Job search strategy (32)
JPM (3)
Labor market (4)
Layoffs (6)
Legal (32)
Longevity (1)
Lung cancer (15)
Lymphoma (11)
Manufacturing (4)
MASH (4)
Medical device (195)
Medtech (196)
Mergers & acquisitions (153)
Metabolic disorders (10)
Multiple sclerosis (2)
Neurodegenerative disease (6)
Neuroscience (56)
NextGen: Class of 2026 (71)
Non-profit (36)
Obesity (4)
Opinion (2)
Ovarian cancer (5)
Pain (1)
Pancreatic cancer (5)
Parkinson's disease (5)
Partnered (1)
Patents (5)
Patient recruitment (8)
People (618)
Phase 1 (406)
Phase 2 (582)
Phase 3 (564)
Pipeline (125)
Policy (1)
Postmarket research (59)
Preclinical (96)
Prostate cancer (6)
Psychedelics (3)
Radiopharmaceuticals (2)
Rare diseases (14)
Real estate (23)
Regulatory (262)
Research institute (32)
Resumes & cover letters (10)
RSV (1)
Schizophrenia (1)
Series A (2)
Series B (4)
Sickle cell disease (6)
Special edition (1)
Spinal muscular atrophy (1)
Startups (26)
Tariffs (1)
Vaccines (9)
Venture capital (3)
Weight loss (1)
Women's health (1)
Date
Last 7 days (5)
Last 30 days (21)
Last 365 days (475)
2026 (33)
2025 (479)
2024 (525)
2023 (570)
2022 (635)
2021 (751)
2020 (809)
2019 (598)
2018 (481)
2017 (471)
2016 (263)
2015 (303)
2014 (217)
2013 (187)
2012 (192)
2011 (213)
2010 (160)
Location
Africa (4)
Alabama (2)
Arizona (2)
Asia (489)
Australia (101)
California (180)
Canada (44)
China (16)
Colorado (3)
Connecticut (7)
Delaware (14)
Europe (1265)
Florida (20)
Georgia (2)
Illinois (13)
India (2)
Indiana (11)
Iowa (1)
Japan (23)
Maine (2)
Maryland (9)
Massachusetts (112)
Michigan (3)
Minnesota (10)
Nevada (2)
New Jersey (55)
New York (31)
North Carolina (15)
Northern California (112)
Ohio (1)
Pennsylvania (31)
South America (6)
South Carolina (1)
Southern California (51)
Tennessee (2)
Texas (36)
United States (562)
Utah (1)
Virginia (1)
Washington State (5)
Wisconsin (1)
7,379 Results for "i2o therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
i2o Therapeutics Names Kurt Graves Chairman and CEO, Announces Corporate Updates
i2o Therapeutics, Inc. announced the appointment of Kurt Graves as Chairman, President and CEO.
August 28, 2023
·
7 min read
Business
i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman
i2O Therapeutics, a developer of novel peptide- and antibody-based oral biologic products based on a proprietary ionic liquid platform, today announced the appointment of Kurt C. Graves as Executive Chairman.
October 12, 2021
·
3 min read
Business
i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules
i2O Therapeutics, a developer of oral biologic products based on its proprietary ionic liquid platform, today announced a collaboration and option agreement with Janssen Biotech, Inc., for Janssen Research & Development to evaluate the use of ionic liquid technology for the oral delivery of macromolecules.
January 6, 2022
·
2 min read
Genetown
i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-based Medicines
i2O Therapeutics , developers of a platform for oral delivery of traditionally injectable biological drugs, announced today a research collaboration with Sanofi to investigate the oral delivery of Sanofi’s Nanobody ® -based medicines, which are currently administered through intravenous or subcutaneous injections. Nanobodies - propr
February 10, 2021
·
2 min read
Business
i2O Therapeutics Receives Strategic Investment from Colorcon Ventures and Enters into Research Collaboration with Colorcon
i2O Therapeutics, an innovative biotech company developing a platform to enable oral delivery of traditionally injectable biological drugs, has received a strategic investment from Colorcon Ventures, the corporate venture fund of Colorcon Inc.
December 3, 2020
·
2 min read
Press Releases
/C O R R E C T I O N -- Privo Technologies/
January 26, 2026
·
2 min read
Press Releases
/C O R R E C T I O N -- Orasis Pharmaceuticals/
January 28, 2026
·
8 min read
Press Releases
Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology
January 8, 2026
·
7 min read
Press Releases
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
January 8, 2026
·
3 min read
Press Releases
Oncolytics Biotech® Expands Its Gastrointestinal Tumor Scientific Advisory Board with the Addition of Dr. Eileen O’Reilly, Dr. Neil Segal, and Dr. Van Morris
January 8, 2026
·
7 min read
1 of 738
Next
